Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variet... Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in most breast cancers at low, intermediate, and high or overexpressor levels. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.4 | 3.4188034188 | 11.7 | 12.3 | 11.27 | 22255 | 11.9408114 | CS |
4 | -0.3 | -2.41935483871 | 12.4 | 13 | 11.27 | 20732 | 12.05299792 | CS |
12 | -1.5217 | -11.171146039 | 13.6217 | 14.47 | 10.52 | 30955 | 12.44716008 | CS |
26 | -4.4 | -26.6666666667 | 16.5 | 16.5 | 10.52 | 30317 | 13.27750026 | CS |
52 | -1.95 | -13.8790035587 | 14.05 | 21.44 | 10.52 | 36860 | 14.82533564 | CS |
156 | -7.09 | -36.9463262116 | 19.19 | 24.46 | 6.8241 | 59847 | 12.10260174 | CS |
260 | 7.1 | 142 | 5 | 158.07 | 3.262 | 138366 | 35.88148398 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions